摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

氧代-三氧代-锰 | 14333-13-2

中文名称
氧代-三氧代-锰
中文别名
——
英文名称
Permanganate Ion
英文别名
permanganate
氧代-三氧代-锰化学式
CAS
14333-13-2
化学式
MnO4-
mdl
——
分子量
118.936
InChiKey
NPDODHDPVPPRDJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    2.66 g/cm3
  • 物理描述:
    Generally purplish colored. Soluble in water. Noncombustible, but accelerate the burning of combustible material. If the combustible material is finely divided, the mixture may be explosive. May spontaneously ignite in contact with liquid combustible materials. Contact with sulfuric acid may cause fire or explosion.

计算性质

  • 辛醇/水分配系数(LogP):
    -1.55
  • 重原子数:
    5
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    74.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(4-异丁基苯基)丙醛氧代-三氧代-锰次氯酸离子布洛芬 作用下, 以to obtain the ibuprofen, α-(4-isobutylphenyl)propionic acid的产率得到布洛芬
    参考文献:
    名称:
    Method for producing arylethylene
    摘要:
    一种生产芳基乙烯的方法,包括以下四个步骤:(I)在惰性气体存在下,将1,1-二芳基乙烷与酸催化剂接触,将该化合物裂解成芳基乙烯和烷基苯;(II)将上述裂解步骤(I)得到的反应混合物分离成至少一个主要含有1,1-二芳基乙烷的部分;(III)在氢化催化剂存在下,将主要含有1,1-二芳基乙烷的部分与氢气接触;(IV)通过将前述氢化步骤(III)得到的氢化部分重新带入步骤(I)进行再裂解。特别地,该方法适用于生产对异丁基苯乙烯,该物质是制备宝贵药物布洛芬的起始材料。
    公开号:
    US04855519A1
  • 作为试剂:
    描述:
    6-chloro-2-(4,6-dimethoxypyrimidin-2-yloxy)benzaldehyde 、 potassium permanganateSodium Phosphate, Dibasic, Heptahydratedisodium;dioxido-oxo-sulfanylidene-λ6-sulfane氧代-三氧代-锰 、 two 、 二氯甲烷magnesium sulfate四氯化碳 作用下, 以 丙酮 为溶剂, 反应 18.0h, 以to yield 10.0 grams of 6-chloro-2 -(4,6-dimethoxypyrimidin-2-yloxy)benzoic acid的产率得到2-chloro-6-(4,6-dimethoxypyrimidin-2-yl)oxy benzoic acid
    参考文献:
    名称:
    Herbicidal substituted benzoylsulfonamides
    摘要:
    化学式为##STR1##的化合物,其中A为O、S或NR.sup.3;G为CH或N;R和R.sup.1独立地为烷基、烷氧基、卤代烷氧基或烷基氨基;R.sup.2为苯基、取代苯基、烷基、环烷基、卤代烷基或--CH.sub.2[(R.sup.4)C(R.sup.5).sub.n--Z;R.sup.3和R.sup.7独立地为氢、烷基、--C(O)NH.sub.2或--C(O)烷基;R.sup.4和R.sup.5独立地为氢、烷基或卤素;R.sup.6为卤素、烷基、烷氧基、卤代烷氧基、NO.sub.2、氨基、烷基取代氨基或酰取代氨基;n为0至5;Z为氰基、氨基、烷基氨基、二烷基氨基、--NHCO.sub.2烷基、烷氧基、烷硫基、烷基磺酰基、烯基、炔基、苯基或取代苯基;Q为氢、卤素、烷基、烷氧基、卤代烷氧基、硝基、氨基、卤代烷基、烷硫基、烷基磺酰基、苯基、取代苯基或苯氧基;或具有化学式##STR2##的5或6成员芳香杂环,其中“m”为0或1;A'为O、S或NR.sup.7;X、X'、Y、Y'、W、W'、V、V'、U和Z'独立地为N、O、S、--CH--或--CR.sup.6。还公开了制备苯甲酰磺酰胺的中间体。
    公开号:
    US05149357A1
点击查看最新优质反应信息

文献信息

  • Process for preparing Benzoxepino- or
    申请人:Merck & Co., Inc.
    公开号:US04380645A1
    公开(公告)日:1983-04-19
    Improved yields of Benzoxepino- or Benzthiapino[4,3-b]pyrrole-2-acetic acids have been achieved from processes based on modifications performed on a pyrrole carboxylic ester rather than on a pyrrole-.alpha.-oxoacetate.
    通过对吡咯羧酸酯进行改性而非对吡咯-α-氧乙酸酯进行改性的过程,已经实现了苯并噁呔-或苯并噻呔[4,3-b]吡咯-2-乙酸的提高产率。
  • Analgesic imidazolemethanols
    申请人:Gist-Brocades N.V.
    公开号:US04152441A1
    公开(公告)日:1979-05-01
    .alpha.,.alpha.-Diarylimidazole-2-methanols of the general formula ##STR1## wherein R.sub.1 -R.sub.10 are the same or different and each represents a hydrogen or halogen atom or a trifluoromethyl or tertiary butyl group, with at least one of said R.sub.1 -R.sub.10 being halogen, trifluoromethyl or tertiary butyl; R.sub.11 and R.sub.12 are the same or different and each represents a hydrogen atom, an alkyl group, a phenyl group or a halogen-or trifluoromethyl-substituted phenyl group; and R.sub.13 represents a hydrogen atom or a lower alkyl group, a lower alkoxymethyl group, a phenylalkyl group (optionally substituted in the phenyl moiety by one or more halogen atoms or alkyl or trifluoromethyl groups), an alkenyl group, a phenyl(lower)alkoxymethyl group (optionally substituted in the phenyl moiety by one or more halogen atoms or alkyl or trifluoromethyl groups) or a benzenesulfonyl group (in which the phenyl moiety is optionally substituted by one or more alkyl groups) are described. These compounds and their non-toxic acid addition salts have anorexient activity. Certain of these compounds have analgesic activity comparable to morphine but without its serious side effects. Processes for their manufacture and compositions for their use are described.
    该专利描述了一种.alpha.,.alpha.-二芳基咪唑-2-甲醇的一般式,其中R1-R10相同或不同,分别代表氢原子、卤素原子、三氟甲基或叔丁基基团,其中至少有一个R1-R10为卤素、三氟甲基或叔丁基基团;R11和R12相同或不同,分别代表氢原子、烷基、苯基或卤素或三氟甲基取代的苯基;R13代表氢原子或较低的烷基、较低的烷氧甲基、苯基烷基(在苯基中可以选择地被一个或多个卤素原子或烷基或三氟甲基基团取代)、烯基、苯基(较低)烷氧甲基(在苯基中可以选择地被一个或多个卤素原子或烷基或三氟甲基基团取代)或苯磺酰基(其中苯基可以选择地被一个或多个烷基基团取代)。这些化合物及其无毒的酸加合物具有压抑食欲的活性。其中某些化合物具有与吗啡相当的镇痛活性,但没有其严重的副作用。同时还描述了它们的制造过程和用于它们的组合物。
  • Process for preparing 4-(4'-carboxyphenyl)pyridine
    申请人:Clariant GmbH
    公开号:US20010021778A1
    公开(公告)日:2001-09-13
    The invention relates to a process for preparing 4-(4′-carboxyphenyl)pyridine, which comprises oxidizing a 4-phenyl-N-acyldihydropyridine of the formula (II) 1 where R 1 is a bulky alkyl, alkylaryl, arylalkyl or alkoxy group and R 2 is a straight-chain or branched, substituted or unsubstituted alkyl radical having from 1 to 8 carbon atoms, by means of an oxidizing agent selected from the group consisting of permanganates, nitric acid, Cr(VI) compounds, oxygen and air to give the compound of the formula (I) 2 where M is a cation.
    本发明涉及一种制备4-(4'-羧基苯基)吡啶的方法,包括将式(II)的4-苯基-N-酰基二氢吡啶氧化,其中R1为笨重的烷基、烷基芳基、芳基烷基或烷氧基,R2为具有1至8个碳原子的直链或支链、取代或未取代的烷基基团,氧化剂选自高锰酸盐、硝酸、Cr(VI)化合物、氧气和空气,得到式(I)的化合物,其中M为阳离子。
  • Process for the production of substituted 2-benzoylpyridines
    申请人:Deutsche Gold- und Silber-Scheideanstalt vormals Roessler
    公开号:US03956344A1
    公开(公告)日:1976-05-11
    2-BENZOYLPYRIDINE AND ITS DERIVATIVES SUBSTITUTED IN THE PYRIDINE AND/OR BENZENE RING ARE PREPARED BY OXIDIZING WITH HYDROGEN PEROXIDE OR OTHER PEROXIDE A COMPOUND OF THE FORMULA: ##SPC1## Where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are hydrogen or a group inert under the oxidizing conditions and Y is cyano, carboxy or carbalkoxy in the presence of cyanate ion.
    2-苯甲酰吡啶及其在吡啶和/或苯环上被取代的衍生物,通过在氰酸根离子存在下使用过氧化氢或其他过氧化物氧化式为##SPC1##的化合物,其中R.sub.1,R.sub.2,R.sub.3和R.sub.4是氢或在氧化条件下惰性的基团,Y为氰基,羧基或碳氧烷氧基。
  • Valproate conjugation using dicarbonyls
    申请人:Syva Company
    公开号:US04409325A1
    公开(公告)日:1983-10-11
    .alpha.-substituted derivatives of valproic acid are provided for conjugation to antigenic compositions, particularly poly(amino acids), and enzymes. The antigenic conjugates are employed for the production of antibodies, which find particular use in immunoassays for the determination of valproate, while the enzyme conjugate finds use in a homogeneous enzyme immunoassay for the determination of valproate. The compounds are synthesized by alkylating valproate at the tertiary carbon atom by an aliphatic chain with a terminal double bond which is cleaved to provide an acid or aldehyde group.
    提供了.valproic acid的.alpha.-取代衍生物,用于结合到抗原性组合物,特别是聚(氨基酸)和酶。抗原结合物用于生产抗体,这些抗体在免疫测定中用于测定丙戊酸,而酶结合物则用于测定丙戊酸的均相酶免疫测定。这些化合物通过用具有端部双键的脂肪链烷基化.valproate的三级碳原子,并将其裂解以提供酸或醛基来合成。
查看更多